5 completed, 3 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Unknown 3 |
Follow prednylidene: new trials by email Literature Review of prednylidene trials Research Report on prednylidene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients Telitacicept, Hydroxychloroquine, Prednisone - Systemic Lupus Erythematosus | Phase 4 | Unknown | Fen Li | 30 | 2022-12-31 | 2024-01-17 |
| The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA Iguratimod, Tofacitinib, Pred - Arthritis, Rheumatoid | Phase 4 | Completed | Qilu Hospital of Shandong University | 100 | 2020-03-01 | 2023-11-18 |
| Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis Prednisolone - Lupus Nephritis | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 32 | 2018-07-16 | 2019-10-31 |
| Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients Dasatinib, prednisone, dexamethasone - ph+ Acute Lymphoblastic Leukemia | Phase 4 | Unknown | Tongji Hospital | 40 | 2016-03-01 | 2016-02-24 |
| EDOCH Alternating With DHAP for New Diagnosed Younger MCL Etoposide, Doxorubicin, Dexamethasone - Mantle Cell Lymphoma | Phase 4 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 55 | 2016-01-01 | 2026-02-11 |
| The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment Iguratimod, MTX, HCQ - Arthritis, Rheumatoid | Phase 4 | Completed | Qilu Hospital of Shandong University | 400 | 2016-01-01 | 2023-11-18 |
| CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Cyclophosphamide 750mg/m2, Vincristine 1.4mg/m2, Doxorubicin 50mg/m2 - ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified | Phase 4 | Unknown | Ruijin Hospital | 200 | 2012-09-01 | 2017-11-14 |
| Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma cyclophosphamide, prednisolone, vinblastine sulfate - Lymphoma | Phase 4 | Completed | Christine Mauz-Körholz | 225 | 2009-11-01 | 2023-12-13 |
Arthritis, Rheumatoid (2) · Enteropathy-Associated T-Cell Lymphoma (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Lymphoma (1) · Lymphoma, Mantle-Cell (1) · Subcutaneous panniculitis-like T-cell lymphoma (1)
Qilu Hospital of Shandong University (2) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Christine Mauz-Körholz (1) · Fen Li (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Ruijin Hospital (1) · Tongji Hospital (1)
China (6) · Bangladesh (1) · Germany (1)
Dieter Koerholz, MD (1) · Fen Li, doctor (1) · Li Meng, professor (1) · Ming Lv, Dr. (1) · Prof. Nazrul Islam, FCPS, MD (1) · Shuhua Yi, Doc (1) · Xiaoyun Yang, Dr. (1)
PMID 11511139, PMID 12209517, PMID 1356175, PMID 19369404, PMID 24357015, PMID 29450636, PMID 29515299, PMID 3511372, PMID 38616308, PMID 8815753